Price T Rowe Associates Inc Moderna, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,019,197 shares of MRNA stock, worth $121 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,019,197

Previous 1,107,495 7.97%

Holding current value

$121 Million

Previous $110 Million 1.39%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $7.54 Million - $10.2 Million	-88,298 Reduced 7.97%	1,019,197 $109 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $26.9 Million - $40.5 Million	-387,543 Reduced 25.92%	1,107,495 $110 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $28.3 Million - $37.2 Million	293,604 Added 24.44%	1,495,038 $154 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $48.7 Million - $66 Million	-411,017 Reduced 25.49%	1,201,434 $146 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $151 Million - $220 Million	-1,116,552 Reduced 40.91%	1,612,451 $248 Million

Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $440 Million - $780 Million	-3,714,406 Reduced 57.65%	2,729,003 $490 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $360 Million - $592 Million	3,051,035 Added 89.94%	6,443,409 $762 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $114 Million - $172 Million	973,933 Added 40.27%	3,392,374 $485 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.69 Million - $3.14 Million	-13,367 Reduced 0.55%	2,418,441 $417 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $1.42 Million - $2.31 Million	-6,282 Reduced 0.26%	2,431,808 $618 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $47.8 Million - $104 Million	215,515 Added 9.7%	2,438,090 $938 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $15 Million - $27.1 Million	-115,320 Reduced 4.93%	2,222,575 $522 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $108 Million - $185 Million	993,175 Added 73.86%	2,337,895 $306 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $88.4 Million - $228 Million	1,344,720 New	1,344,720 $140 Million

Others Institutions Holding MRNA

# of Institutions

1,036

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Moderna, Inc. Transaction History